• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[耐多药结核分枝杆菌菌株对二线药物的耐药率]

[The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].

作者信息

Kayali Revasiye, Cöplü Nilay, Ceyhan Ismail, Ocak Fatih, Citil Burak Ekrem, Esen Berrin

机构信息

Refik Saydam Hifzissihha Merkezi Başkanliği, Salgin Hastaliklar Araştirma Müdürlüğü, Ankara.

出版信息

Mikrobiyol Bul. 2006 Jan-Apr;40(1-2):1-7.

PMID:16775950
Abstract

The treatment of multidrug resistant tuberculosis (MDR-TB) requires the use of minor antituberculosis drugs, thus susceptibilities against these minor drugs should be performed. The aim of this study was to establish and standardize the susceptibility testing methods for minor antituberculosis drugs in this laboratory and to obtain data about the resistance rates. Drug susceptibility tests were performed by proportion method in Lowenstein-Jensen media for 50 MDR Mycobacterium tuberculosis isolates that have been collected from different regions of our country. Resistance rates to ethionamide, cycloserin, kanamycin, p-aminosalicylic acid, ofloxacin, thiacetasone, and capreomycin were found as 22%, 8%, 6%, 6%, 2%, 2%, and 0%, respectively. Multidrug resistance was observed in 8% of the isolates. As a result, the resistance rates of multidrug resistant M. tuberculosis strains against the tested minor antituberculosis drugs seem to be low in this study.

摘要

耐多药结核病(MDR-TB)的治疗需要使用二线抗结核药物,因此应检测对这些二线药物的敏感性。本研究的目的是在本实验室建立并标准化二线抗结核药物的药敏试验方法,并获取耐药率数据。采用比例法在罗-琴培养基上对从我国不同地区收集的50株耐多药结核分枝杆菌进行药敏试验。乙硫异烟胺、环丝氨酸、卡那霉素、对氨基水杨酸、氧氟沙星、硫乙酰胺和卷曲霉素的耐药率分别为22%、8%、6%、6%、2%、2%和0%。8%的分离株观察到耐多药。结果,本研究中耐多药结核分枝杆菌菌株对所检测的二线抗结核药物的耐药率似乎较低。

相似文献

1
[The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].[耐多药结核分枝杆菌菌株对二线药物的耐药率]
Mikrobiyol Bul. 2006 Jan-Apr;40(1-2):1-7.
2
Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates.泰国耐多药结核分枝杆菌分离株的二线药物敏感性
Int J Tuberc Lung Dis. 2005 Feb;9(2):216-9.
3
Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.卢旺达耐多药结核分枝杆菌分离株中二线药物耐药水平较低。
Int J Infect Dis. 2008 Mar;12(2):152-6. doi: 10.1016/j.ijid.2007.05.003. Epub 2007 Oct 18.
4
Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.1995 - 2002年香港实施强化直接督导短程化疗(DOTS-plus)后结核分枝杆菌对二线药物的敏感性监测
Int J Tuberc Lung Dis. 2004 Jun;8(6):760-6.
5
[Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].[采用E-test法评估耐多药结核分枝杆菌复合群分离株的二线抗结核药物敏感性]
Mikrobiyol Bul. 2015 Jan;49(1):47-55. doi: 10.5578/mb.8602.
6
[Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs].[从地区结核病实验室收集的结核分枝杆菌菌株对主要抗结核药物的敏感性]
Mikrobiyol Bul. 2007 Jul;41(3):403-9.
7
Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.俄罗斯阿尔汉格尔斯克州耐多药结核分枝杆菌菌株对二线抗结核药物的耐药性。
Eur J Clin Microbiol Infect Dis. 2005 Mar;24(3):202-6. doi: 10.1007/s10096-005-1284-z.
8
Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.二线药物敏感性试验与结核病再治疗:回顾早期经验
Medicina (B Aires). 2007;67(3):231-7.
9
Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.2000年至2006年期间,台湾某医疗中心耐药性呈下降趋势,但同时出现了广泛耐药结核分枝杆菌。
Clin Infect Dis. 2008 Oct 1;47(7):e57-63. doi: 10.1086/591702.
10
Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance.确定具有临床和微生物学相关性的二线抗结核药物的临界浓度。
Int J Tuberc Lung Dis. 2010 Mar;14(3):282-8.